GlassScriptPhysician profile
Howard Y Lee
NPI 1124255716
$841.16
in general payments reported to CMS, 2019-2025
16 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.11 · 2020: $77.94 · 2021: $60.19 · 2022: $33.54 · 2023: $40.12 · 2024: $304 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $337.75 | 2021-2025 | Watchman Flx, Avvigo Guidance System, Watchman Access System |
| Lantheus Medical Imaging, INC. | $122.84 | 2019-2023 | Definity |
| Amgen INC. | $62.82 | 2024-2025 | Repatha, Repatha |
| Medtronic, INC. | $60.47 | 2022-2025 | Micra |
| Astellas Pharma US INC | $35.14 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $30.49 | 2024 | Camzyos, Eliquis |
| Abiomed | $28.58 | 2024 | Impella |
| Abbott Laboratories | $24.78 | 2025 | Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.24 | 2025 | Lifevest |
| Merck Sharp & Dohme LLC | $19.21 | 2025 | Verquvo |
| Medtronic Vascular, INC. | $17.23 | 2019 | |
| Siemens Medical Solutions USA, INC. | $17.21 | 2022 | |
| Novo Nordisk INC | $16.06 | 2025 | Wegovy |
| Pfizer INC. | $15.88 | 2020 | |
| Irhythm Technologies, INC. | $14.86 | 2024 | Zio Monitor, Zio Xt Patch |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.